Back in early 2020, as the then-novel SARS-CoV-2 spread across Earth, doctors began to notice a phenomenon only seen previously in a lab: specific types of antidepressants appeared to help people heal ...
COVID-19 patients on an antidepressant were less likely to die from the infection, a retrospective study found. Compared with patients not on an antidepressant, patients with COVID-19 who were taking ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
The antidepressant fluvoxamine reduced the need for hospitalization among high-risk patients with COVID-19, according to results of the randomized, placebo-controlled TOGETHER trial. “[Fluvoxamine] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results